Shenzhen Haipulos Biotechnology ^Company

Hypros is the world's leading high-tech enterprise in precision medical and genetic big data. The company is committed to integrating cutting-edge emerging technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data. It focuses on the whole process of diagnosis and treatment of cancer patients, and is determined to use technology to improve the quality of life and make every life healthy for 120 years. Hypros has completed the multi-center globalization of Shenzhen R&D Headquarters, Third-Party Medical Laboratory, GMP Production Workshop, US R&D Center, Hypus Genome Center and Shangrao International Precision Medical Health Industrial Park. The company invested hundreds of millions of dollars to introduce the world's most advanced Illumina NovaSeq6000, HiSeq X Ten, NextSeq500/550 series sequencing platform and digital PCR platform, successfully built the world's top genetic testing center. At present, the company's sequencing throughput is the second in the world, and the output of tumor gene data ranks in the forefront of the country. The business covers 300+ top three hospitals in more than 30 provinces.